Southeast Asia needs a revolving fund for vaccines
Lancet Glob Health
.
2022 Nov;10(11):e1557-e1558.
doi: 10.1016/S2214-109X(22)00406-5.
Authors
Fariza Nasreen Seraj Ahmad
1
,
Swee Kheng Khor
2
,
Jeremy Lim
2
,
Susann Roth
3
,
Shita Dewi
4
,
Francisco Becerra
5
Affiliations
1
Health Equity Initiatives, Kuala Lumpur 50470, Malaysia. Electronic address:
[email protected]
.
2
Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
3
Asian Development Bank, Manila, Philippines.
4
Center for Health Policy and Management, Universitas Gadjah Mada, Yogyakarta, Indonesia.
5
Global Health Consortium, Florida International University, Miami, FL, USA; CDICS, Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico.
PMID:
36240817
PMCID:
PMC9553198
DOI:
10.1016/S2214-109X(22)00406-5
No abstract available
MeSH terms
Asia, Southeastern
Financial Management*
Humans
Vaccines*
Substances
Vaccines